Concourse Financial Group Securities, Inc. Astrazeneca PLC Transaction History

Concourse Financial Group Securities, Inc.

  • $0
  • Q2 2025
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
100.0%
Previous 100.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$64.87 - $75.0 $0 - $0
0 New
0 $0
Q1 2025

May 14, 2025
SELL
$65.37 - $77.96 $1.83 Million - $2.18 Million
-27,951 Closed
0 $0
Q4 2024

Feb 13, 2025
BUY
$63.2 - $79.58 $167,480 - $210,887
2,650 Added 10.47%
27,951 $1.83 Million
Q3 2024

Oct 10, 2024
BUY
$76.67 - $87.62 $326,460 - $373,085
4,258 Added 20.23%
25,301 $1.97 Million
Q2 2024

Jul 23, 2024
BUY
$66.81 - $80.83 $87,387 - $105,725
1,308 Added 6.63%
21,043 $1.64 Million
Q1 2024

Apr 30, 2024
BUY
$61.03 - $69.57 $55,903 - $63,726
916 Added 4.87%
19,735 $1.34 Million
Q4 2023

Feb 07, 2024
BUY
$61.89 - $69.28 $437,129 - $489,324
7,063 Added 60.08%
18,819 $1.27 Million
Q3 2023

Oct 25, 2023
SELL
$64.85 - $71.7 $19,844 - $21,940
-306 Reduced 2.54%
11,756 $796,000
Q2 2023

Aug 10, 2023
BUY
$69.91 - $75.81 $58,235 - $63,149
833 Added 7.42%
12,062 $863,000
Q1 2023

May 15, 2023
BUY
$63.15 - $71.6 $631,310 - $715,785
9,997 Added 811.44%
11,229 $779,000
Q4 2022

Jan 30, 2023
BUY
$54.21 - $70.44 $542 - $704
10 Added 0.82%
1,232 $0
Q3 2022

Nov 15, 2022
BUY
$53.02 - $135.75 $848 - $2,172
16 Added 1.33%
1,222 $67,000
Q2 2022

Aug 09, 2022
SELL
$59.26 - $71.14 $20,918 - $25,112
-353 Reduced 22.64%
1,206 $80,000
Q1 2022

May 09, 2022
SELL
$55.72 - $67.12 $144,760 - $174,377
-2,598 Reduced 62.5%
1,559 $104,000
Q4 2021

Feb 07, 2022
BUY
$54.02 - $63.83 $4,105 - $4,851
76 Added 1.86%
4,157 $242,000
Q3 2021

Nov 09, 2021
BUY
$55.56 - $60.79 $12,334 - $13,495
222 Added 5.75%
4,081 $245,000
Q2 2021

Aug 13, 2021
SELL
$48.42 - $60.18 $8,134 - $10,110
-168 Reduced 4.17%
3,859 $231,000
Q1 2021

May 13, 2021
BUY
$47.16 - $54.44 $147,610 - $170,397
3,130 Added 348.94%
4,027 $200,000
Q4 2020

Feb 02, 2021
SELL
$48.52 - $58.02 $3,153 - $3,771
-65 Reduced 6.76%
897 $45,000
Q3 2020

Nov 13, 2020
BUY
$53.07 - $61.1 $1,804 - $2,077
34 Added 3.66%
962 $53,000
Q2 2020

Aug 13, 2020
BUY
$43.1 - $55.31 $2,284 - $2,931
53 Added 6.06%
928 $49,000
Q1 2020

May 13, 2020
BUY
$37.79 - $51.33 $33,066 - $44,913
875 New
875 $39,000
Q4 2019

Feb 14, 2020
BUY
$42.46 - $50.46 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$40.12 - $45.47 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
SELL
$37.28 - $41.68 $73,106 - $81,734
-1,961 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$35.49 - $43.02 $7,914 - $9,593
223 Added 12.83%
1,961 $79,000
Q4 2018

Feb 14, 2019
BUY
$36.86 - $41.49 $20,641 - $23,234
560 Added 47.54%
1,738 $66,000
Q3 2018

Nov 13, 2018
BUY
$34.76 - $39.72 $40,947 - $46,790
1,178 New
1,178 $47,000

Others Institutions Holding AZN

# of Institutions
1,465
Shares Held
493M
Call Options Held
7.22M
Put Options Held
2.67M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $276B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email